integrating it with gamma. for distribution and catalog development. And Jackson hasn’t exactly been shy about sharing his views on what he deems an outdated major label system still steeped in ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been approved by the Danish ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

EXCLUSIVE: Jason Hellerstein, a co-founding executive of the distributor Sideshow is opening the doors to 1-2 Special, a new North American film distribution company focused on acquiring and ...

TC BioPharm (NASDAQ: TCBP) announced that CEO Bryan Kobel will participate in the Cancer Progress Panel at the 18th Annual European Life Sciences CEO ...

TC BioPharm (NASDAQ: TCBP) announced the completion of patient dosing in Cohort A of its ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 for re ...